Innovation OsteoLign is developing a novel, minimally invasive method and apparatus for treating mid-shaft long bone fractures using an intermedullary stent and fixative agent.
Funding OsteoLign has raised $13.8 million in its Series A and B financings.
Contact 5885 Ridgeway Center Parkway, Suite 210
Memphis, TN 38120
901.213.5151 phone
901.213.5155 fax
